Ally Bridge Group (NY) LLC
10% Owner

Ally Bridge Group (NY) LLC insider trades: ProMIS Neurosciences (PMN) stock purchases

10% Owner, ProMIS Neurosciences Last trade Feb 3, 2026 11 Form 4 filings
$0
Sold, last 12 months
0 sales
$8.5M
Bought, last 12 months
1 buy
8
Open-market trades
since 2020
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ally Bridge Group (NY) LLC reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 3, 2026PMN↑ Buy$8.5M
Apr 4, 2022MDVL↑ Buy$15.0M
Dec 31, 2020MDVL↑ Buy$190K
Dec 29, 2020MDVL↑ Buy$101K
Dec 24, 2020MDVL↑ Buy$660K
Dec 21, 2020MDVL↑ Buy$470K
Dec 17, 2020MDVL↑ Buy$570K
Dec 15, 2020MDVL↑ Buy$556K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PMN insiders

Open-market trades in the last 12 months

About Ally Bridge Group (NY) LLC's insider trades

Ally Bridge Group (NY) LLC is a 10% owner of ProMIS Neurosciences (PMN). Since Dec 15, 2020, it has reported 8 open-market purchases worth $26.0M and no sales on SEC Form 4. In the last 12 months: 1 buy ($8.5M).

Its filings also include other transactions (4 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PMN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.